Posted on January 20th, 2012 by
Almost $4 million in fresh funding is giving a boost to a Belgium regenerative medicine firm as it gears up its new Rochester office. Cardio3 BioSciences, in which Mayo Clinic owns equity through an intellectual property license, announced Tuesday that it secured almost $4 million, or 3.1 million euros, in its latest round of funding. Additional coverage: Post-Bulletin Blog
Post-Bulletin, by Jeff Kiger, 1/11/2012
You must be logged-in to the site to post a comment.